<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00005775</url>
  </required_header>
  <id_info>
    <org_study_id>NICHD-NRN-0020</org_study_id>
    <secondary_id>U10HD027856</secondary_id>
    <secondary_id>U10HD021364</secondary_id>
    <secondary_id>U10HD034216</secondary_id>
    <secondary_id>U10HD034167</secondary_id>
    <secondary_id>U10HD021397</secondary_id>
    <secondary_id>U10HD027853</secondary_id>
    <secondary_id>U10HD027871</secondary_id>
    <secondary_id>U10HD021415</secondary_id>
    <secondary_id>U10HD027904</secondary_id>
    <secondary_id>U10HD027881</secondary_id>
    <secondary_id>U10HD021385</secondary_id>
    <secondary_id>U10HD027851</secondary_id>
    <secondary_id>U10HD027880</secondary_id>
    <secondary_id>U10HD021373</secondary_id>
    <secondary_id>U01HD036790</secondary_id>
    <secondary_id>M01RR008084</secondary_id>
    <secondary_id>M01RR006022</secondary_id>
    <secondary_id>M01RR000750</secondary_id>
    <secondary_id>M01RR000997</secondary_id>
    <secondary_id>M01RR000070</secondary_id>
    <secondary_id>M01RR001032</secondary_id>
    <nct_id>NCT00005775</nct_id>
  </id_info>
  <brief_title>Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants</brief_title>
  <acronym>Glutamine</acronym>
  <official_title>Randomized Controlled Trial of Parenteral Glutamine Supplementation for Extremely-Low-Birth-Weight (ELBW) Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NICHD Neonatal Research Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>NICHD Neonatal Research Network</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This large multicenter double-masked clinical trial tested whether supplementation of
      standard neonatal parenteral nutrition with glutamine would reduce the risk of death or
      late-onset sepsis in extremely-low-birth-weight (ELBW, less than or equal to 1000 gm)
      infants. Neonates with birth weights of 401-1000gm were randomized to standard TrophAmine or
      TrophAmine supplemented with glutamine before 72 hours and continued until the infants are
      tolerating full enteral feedings.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Meeting the protein and energy requirements of extremely premature infants in early postnatal
      life requires early hyperalimentation and the gradual introduction of enteral feedings.
      Glutamine, which is the most abundant amino acid in the human body and taken up in greatest
      quantity by the fetus from the placenta, is not routinely provided in neonatal parenteral
      nutrition preparations.

      This large multicenter double-masked clinical trial tested whether supplementation of
      standard neonatal parenteral nutrition with glutamine would reduce the risk of death or
      late-onset sepsis in extremely-low-birth-weight (ELBW, less than or equal to 1000 gm)
      infants. Neonates with birth weights of 401-1000gm were randomized to standard TrophAmine or
      TrophAmine supplemented with glutamine before 72 hours and continued until the infants are
      tolerating full enteral feedings.

      Infants received a neurodevelopmental assessment by masked, certified examiners at 18-22
      months postmenstrual age.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 1999</start_date>
  <completion_date type="Actual">August 2001</completion_date>
  <primary_completion_date type="Actual">December 2000</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Death or late-onset sepsis</measure>
    <time_frame>At hospital discharge</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tolerance of enteral feeding (number of days to reach full enteral feeds) and decrease number of episodes of feeding intolerance</measure>
    <time_frame>At hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Necrotizing Enterocolitis</measure>
    <time_frame>At hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Episodes of late-onset sepsis</measure>
    <time_frame>At hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Growth (days to reach 1500 grams)</measure>
    <time_frame>At hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days on parenteral nutrition</measure>
    <time_frame>At hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in NICU</measure>
    <time_frame>At hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurodevelopmental outcome</measure>
    <time_frame>18-22 months corrrected age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Levels of pro-inflammatory cytokines</measure>
    <time_frame>In the perinatal period</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1433</enrollment>
  <condition>Infant, Newborn</condition>
  <condition>Infant, Low Birth Weight</condition>
  <condition>Infant, Small for Gestational Age</condition>
  <condition>Infant, Premature</condition>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>Glutamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TrophAmine (B. Braun/McGaw) with cysteine hydrochloride (40mg/gm amino acids) with L-glutamine added (20% of the total amount of amino acids)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Standard TrophAmine (B. Braun/McGaw) with cysteine hydrochloride (40mg/gm amino acids)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glutamine</intervention_name>
    <description>Infants randomized to glutamine supplementation will receive glutamine any time that parenteral nutrition is required during the first 120 days of hospitalization.</description>
    <arm_group_label>Glutamine</arm_group_label>
    <other_name>L-Glutamine</other_name>
    <other_name>TrophAmine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>TrophAmine given any time that parenteral nutrition is required during the first 120 days of hospitalization.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>TrophAmine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  401-1000 gm

          -  More than 12 hrs and less than 72 hrs after birth; intravenous access

          -  Parental consent

        Exclusion Criteria:

          -  One or more major congenital anomalies

          -  Infants meeting criteria for terminal illness

          -  Congenital nonbacterial infection with overt signs at birth
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>72 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brenda B. Poindexter, MD MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Waldemar A. Carlo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Neil N. Finer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Diego</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Avroy A. Fanaroff, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Case Western Reserve University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Edward F. Donovan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Medical Center, Cincinnati</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Barbara J. Stoll, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Charles R. Bauer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lu-Ann Papile, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of New Mexico</affiliation>
  </overall_official>
  <overall_official>
    <last_name>W. Kenneth Poole, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>RTI International</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David K. Stevenson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sheldon B. Korones, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Tennessee</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jon E. Tyson, MD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abbot R. Laptook, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Southwestern Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seetha Shankaran, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wayne State University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William Oh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Women and Infants Hospital, Brown University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Richard A. Ehrenkranz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California at San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103-8774</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale University</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wayne State University</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of New Mexico</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>RTI International</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Case Western Reserve University, Rainbow Babies and Children's Hospital</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brown University, Women &amp; Infants Hospital of Rhode Island</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center at Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://neonatal.rti.org/</url>
    <description>NICHD Neonatal Research Network</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/15674878</url>
    <description>Click here for the Cochrane review &quot;Glutamine supplementation for preventionof morbidity in the preterm infant.&quot;</description>
  </link>
  <link>
    <url>https://www.nichd.nih.gov/about/org/der/branches/ppb/Pages/overview.aspx</url>
    <description>NICHD Pregnancy &amp; Perinatology Branch</description>
  </link>
  <results_reference>
    <citation>Poindexter BB, Ehrenkranz RA, Stoll BJ, Koch MA, Wright LL, Oh W, Papile LA, Bauer CR, Carlo WA, Donovan EF, Fanaroff AA, Korones SB, Laptook AR, Shankaran S, Stevenson DK, Tyson JE, Lemons JA; National Institute of Child Health and Human Development Neonatal Research Network. Effect of parenteral glutamine supplementation on plasma amino acid concentrations in extremely low-birth-weight infants. Am J Clin Nutr. 2003 Mar;77(3):737-43.</citation>
    <PMID>12600870</PMID>
  </results_reference>
  <results_reference>
    <citation>Poindexter BB, Ehrenkranz RA, Stoll BJ, Wright LL, Poole WK, Oh W, Bauer CR, Papile LA, Tyson JE, Carlo WA, Laptook AR, Narendran V, Stevenson DK, Fanaroff AA, Korones SB, Shankaran S, Finer NN, Lemons JA; National Institute of Child Health and Human Development Neonatal Research Network. Parenteral glutamine supplementation does not reduce the risk of mortality or late-onset sepsis in extremely low birth weight infants. Pediatrics. 2004 May;113(5):1209-15.</citation>
    <PMID>15121931</PMID>
  </results_reference>
  <results_reference>
    <citation>Oh W, Poindexter BB, Perritt R, Lemons JA, Bauer CR, Ehrenkranz RA, Stoll BJ, Poole K, Wright LL; Neonatal Research Network. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. J Pediatr. 2005 Dec;147(6):786-90.</citation>
    <PMID>16356432</PMID>
  </results_reference>
  <results_reference>
    <citation>Poindexter BB, Langer JC, Dusick AM, Ehrenkranz RA; National Institute of Child Health and Human Development Neonatal Research Network. Early provision of parenteral amino acids in extremely low birth weight infants: relation to growth and neurodevelopmental outcome. J Pediatr. 2006 Mar;148(3):300-305.</citation>
    <PMID>16615955</PMID>
  </results_reference>
  <results_reference>
    <citation>Vohr BR, Poindexter BB, Dusick AM, McKinley LT, Wright LL, Langer JC, Poole WK; NICHD Neonatal Research Network. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age. Pediatrics. 2006 Jul;118(1):e115-23.</citation>
    <PMID>16818526</PMID>
  </results_reference>
  <results_reference>
    <citation>Vohr BR, Poindexter BB, Dusick AM, McKinley LT, Higgins RD, Langer JC, Poole WK; National Institute of Child Health and Human Development National Research Network. Persistent beneficial effects of breast milk ingested in the neonatal intensive care unit on outcomes of extremely low birth weight infants at 30 months of age. Pediatrics. 2007 Oct;120(4):e953-9.</citation>
    <PMID>17908750</PMID>
  </results_reference>
  <results_reference>
    <citation>Meinzen-Derr J, Poindexter B, Wrage L, Morrow AL, Stoll B, Donovan EF. Role of human milk in extremely low birth weight infants' risk of necrotizing enterocolitis or death. J Perinatol. 2009 Jan;29(1):57-62. doi: 10.1038/jp.2008.117. Epub 2008 Aug 21.</citation>
    <PMID>18716628</PMID>
  </results_reference>
  <results_reference>
    <citation>Peralta-Carcelen M, Moses M, Adams-Chapman I, Gantz M, Vohr BR; NICHD Neonatal Research Network; National Institutes of Health. Stability of neuromotor outcomes at 18 and 30 months of age after extremely low birth weight status. Pediatrics. 2009 May;123(5):e887-95. doi: 10.1542/peds.2008-0135.</citation>
    <PMID>19403482</PMID>
  </results_reference>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 1, 2000</study_first_submitted>
  <study_first_submitted_qc>June 1, 2000</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2000</study_first_posted>
  <last_update_submitted>June 3, 2015</last_update_submitted>
  <last_update_submitted_qc>June 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 8, 2015</last_update_posted>
  <responsible_party>
    <name_title>Brenda B. Poindexter, Lead Principal Investigator</name_title>
    <organization>Indiana University</organization>
  </responsible_party>
  <keyword>NICHD Neonatal Research Network</keyword>
  <keyword>Extremely Low Birth Weight (ELBW) infants</keyword>
  <keyword>Prematurity</keyword>
  <keyword>Glutamine</keyword>
  <keyword>Total parenteral nutrition</keyword>
  <keyword>Nutrition</keyword>
  <keyword>Very low birth weight (VLBW) infants</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Birth Weight</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amino-acid, glucose, and electrolyte solution</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

